These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33910128)

  • 1. Natural products for treatment of Plasmodium falciparum malaria: An integrated computational approach.
    Muhseen ZT; Hameed AR; Al-Bhadly O; Ahmad S; Li G
    Comput Biol Med; 2021 Jul; 134():104415. PubMed ID: 33910128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria.
    Wadood A; Ghufran M; Hassan SF; Khan H; Azam SS; Rashid U
    Pharm Biol; 2017 Dec; 55(1):19-32. PubMed ID: 27650666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel compounds and repurposing of FDA drugs for 1-deoxy-D-xylulose 5-phosphate reductoisomerase enzyme of Plasmodium falciparum to combat malaria resistance.
    Aziz S; Waqas M; Naz HF; Halim SA; Jan A; Muhsinah AB; Khan A; Al-Harrasi A
    Int J Biol Macromol; 2024 Feb; 257(Pt 2):128672. PubMed ID: 38092105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparum.
    Umeda T; Tanaka N; Kusakabe Y; Nakanishi M; Kitade Y; Nakamura KT
    Sci Rep; 2011; 1():9. PubMed ID: 22355528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of natural compound inhibitors against PfDXR: A hybrid structure-based molecular modeling approach and molecular dynamics simulation studies.
    Manhas A; Patel D; Lone MY; Jha PC
    J Cell Biochem; 2019 Sep; 120(9):14531-14543. PubMed ID: 30994966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The malarial drug target Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (PfDXR): development of a 3-D model for identification of novel, structural and functional features and for inhibitor screening.
    Goble JL; Adendorff MR; de Beer TA; Stephens LL; Blatch GL
    Protein Pept Lett; 2010 Jan; 17(1):109-20. PubMed ID: 20214634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The druggable antimalarial target PfDXR: overproduction strategies and kinetic characterization.
    Goble JL; Johnson H; de Ridder J; Stephens LL; Louw A; Blatch GL; Boshoff A
    Protein Pept Lett; 2013 Feb; 20(2):115-24. PubMed ID: 22894148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-guided design and biosynthesis of a novel FR-900098 analogue as a potent Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr) inhibitor.
    Cobb RE; Bae B; Li Z; DeSieno MA; Nair SK; Zhao H
    Chem Commun (Camb); 2015 Feb; 51(13):2526-8. PubMed ID: 25567100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structural biology for developing antimalarial compounds].
    Tanaka N; Umeda T; Kusakabe Y; Nakanishi M; Kitade Y; Nakamura KT
    Yakugaku Zasshi; 2013; 133(5):527-37. PubMed ID: 23649394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.
    Jomaa H; Wiesner J; Sanderbrand S; Altincicek B; Weidemeyer C; Hintz M; Türbachova I; Eberl M; Zeidler J; Lichtenthaler HK; Soldati D; Beck E
    Science; 1999 Sep; 285(5433):1573-6. PubMed ID: 10477522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview.
    Proteau PJ
    Bioorg Chem; 2004 Dec; 32(6):483-93. PubMed ID: 15530989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylerythritol phosphate pathway to isoprenoids: kinetic modeling and in silico enzyme inhibitions in Plasmodium falciparum.
    Singh VK; Ghosh I
    FEBS Lett; 2013 Sep; 587(17):2806-17. PubMed ID: 23816706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentials of Terpenoids as Inhibitors of Multiple Plasmodium falciparum Protein Drug Targets.
    Ishola AA; Adewole KE; Adebayo JO; Balogun EA
    Acta Parasitol; 2023 Dec; 68(4):793-806. PubMed ID: 37603126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against Malaria.
    Wang X; Edwards RL; Ball H; Johnson C; Haymond A; Girma M; Manikkam M; Brothers RC; McKay KT; Arnett SD; Osbourn DM; Alvarez S; Boshoff HI; Meyers MJ; Couch RD; Odom John AR; Dowd CS
    J Med Chem; 2018 Oct; 61(19):8847-8858. PubMed ID: 30192536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) enzyme.
    Singh N; Chevé G; Avery MA; McCurdy CR
    Curr Pharm Des; 2007; 13(11):1161-77. PubMed ID: 17430177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of alpha,beta-unsaturated alpha-aryl-substituted fosmidomycin analogues as DXR inhibitors.
    Devreux V; Wiesner J; Jomaa H; Van der Eycken J; Van Calenbergh S
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4920-3. PubMed ID: 17583502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
    Saxena S; Durgam L; Guruprasad L
    J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and bioactivity of β-substituted fosmidomycin analogues targeting 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
    Chofor R; Sooriyaarachchi S; Risseeuw MD; Bergfors T; Pouyez J; Johny C; Haymond A; Everaert A; Dowd CS; Maes L; Coenye T; Alex A; Couch RD; Jones TA; Wouters J; Mowbray SL; Van Calenbergh S
    J Med Chem; 2015 Apr; 58(7):2988-3001. PubMed ID: 25781377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting metacaspase-3 from
    Kumar B; Mohammad T; Amaduddin ; Hussain A; Islam A; Ahmad F; Alajmi MF; Singh S; Pandey KC; Hassan MI; Abid M
    J Biomol Struct Dyn; 2021 Feb; 39(2):421-430. PubMed ID: 31900062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.